Topical composition for the treatment of psoriasis and related skin disorders
AssigneeBioDerm, Inc.
InventorLorraine Faxon Meisner
Life of this patent
Estimating the term…
Abstract
Compositions and methods of use thereof for the treatment of psoriasis and related skin ailments are disclosed. The compositions include topical skin formulations of glucosamine in an emollient base such as moisturizing cream. In addition to glucosamine, the formulations may include keratolytic substances such as coal tar extract or salicylic acid. The formulations may also include glucosamine and antioxidant anti-inflammatory herbal extracts such as oleuropein and berberine in an emollient base.
Claims21
A topical skin preparation adapted-to-the treatment of psoriasis, the preparation comprising:
- a pharmaceutically effective amount of glucosamine, or salt thereof, in an approximate amount of more than 5% of the preparation by weight;
- a pharmaceutically effective amount of berberine, or salt thereof, in an approximate amount of at least 1% by weight;
- and
- a pharmaceutically effective amount of oleuropein, or salts thereof, in an approximate amount of at least 0.5% by weight of the preparation.
A topical skin preparation comprising:
- glucosamine, or pharmaceutically acceptable salts thereof, in an approximate amount of more than 5% of the preparation by weight;
- berberine, or pharmaceutically acceptable salts thereof, in an approximate amount of at least 1% by weight;
- and
- oleuropein, or pharmaceutically acceptable salts thereof, in an approximate amount of at least 0.5% by weight of the preparation.
A topical skin preparation comprising glucosamine;
- berberine and oleuropine, wherein the relative amounts of glucosamine, berberine and oleuropein comprise a ratio of approximately 9:1.75:1 of glucosamine, berberine and oleuropein, respectively.
Dependencies are inferred from the claim text.